Archive:2024
-
Discord’s April Fools’ Loot Box Video: A Blatant Disregard for Ongoing Genocide in Gaza by Archit Mehta
This April Fool’s Day, Discord uploaded a 17-second video. The video shows an object fired from outer space towards the Earth. In the next frame, the object is revealed — a loot box — when it falls on Discord’s mascot, Wumpus. About three weeks prior to Discord’s video, five Palestinians were killed, and 11 were wounded by humanitarian airdrops carried by the US and Jordan.
Categories: 2024, The Gnovis Blog
-
The Culture Industry: ‘Clean Girls,’ Coastal Grandmothers, and TikTok Consumerism by Riley Tinlin
TikTok has become the new mouthpiece for the conglomerate, spoken in pretty shiny words by girls who claim to be just like you. We become convinced that by participating (both socially and economically) in these trends, our identity will be validated. Still, instead, we are left unfulfilled, perpetuating a constant cycle of passive consumption and alienation.
Categories: 2024, The Gnovis Blog
-
Re-Assessing the Consumer Welfare Standard by Ramat Jose
Last Thursday, the Justice Department filed a civil antitrust suit against Apple for monopolizing the App Store and thus violating the Sherman Act. This is a significant case that has the potential to revolutionize the App Store and how we interact with our iPhones.
Categories: 2024, The Gnovis Blog
-
Navigating the Labyrinth: Misinformation and AI in the Information Age by Maria Fernanda Chanduví
What is truly concerning is the increasing sophistication of deepfakes, which are becoming more difficult to distinguish from genuine content. Election season is a particular target for misinformation and deep fakes, and the potential for widespread use of deepfakes is concerning, especially regarding vulnerable demographics.
Categories: 2024, The Gnovis Blog
-
Neuralink: A Bold Experiment from the Tech Mogul? by Yixiao Song
Yet another of Elon Musk’s rockets exploded recently. One wonders what euphemisms Musk will use for his potentially disastrous experiments with human brains. Neuralink, the biotech company founded by Elon Musk, received FDA approval for its first human clinical trial last May.
Categories: 2024, The Gnovis Blog